Autolus Therapeutics Plc (AUTL)
1.63
+0.04
(+2.52%)
USD |
NASDAQ |
May 15, 16:00
1.60
-0.03
(-1.84%)
After-Hours: 20:00
Autolus Therapeutics EPS Diluted (Quarterly) : -0.2686 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 0.00 |
| Mereo BioPharma Group Plc | -0.0418 |
| Cellectis SA | -0.1774 |
| Akari Therapeutics Plc | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -71.48M |
| Revenue (Quarterly) | 26.17M |
| Total Expenses (Quarterly) | 97.65M |
| Enterprise Value | 572.01M |
| Gross Profit Margin (Quarterly) | 6.29% |
| Profit Margin (Quarterly) | -273.1% |
| Earnings Yield | -66.58% |
| Normalized Earnings Yield | -66.52 |